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Abstract A rapid method is described for measuring the antiox- 
idant activity of low density lipoproteins. Studies were undertaken 
on individuals attending a hyperlipidaemia clinic, an unsupple- 
mented group and a group after supplementation with 300 mg 
dl-a-tocopherol acetate for nine weeks. The results show a posi- 
tive correlation between the antioxidant activity and a-tocopherol 
content of LDL in the supplemented group. 
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1. Introduction 
The importance of antioxidants in the maintenance of health 
and protection from disease is becoming increasingly well- 
recognised [1] and in particular the levels of individual antioxi- 
dant nutrients required for optimal health [2]. Several methods 
have been developed recently for monitoring the total antioxi- 
dant activity (i.e. the total collective potential of the constituent 
antioxidants to scavenge radicals) of plasma [3 7], saliva [8], 
pure antioxidant compounds [9], food extracts and beverages 
[10 12]. The methods are based on the composite hydrogen- 
donating abilities of the antioxidants in the matrix in question 
to scavenge generated radicals to an extent and on a timescale 
dependent on their total antioxidant potential. However, a 
major question where body fluids are concerned is the contribu- 
tion from unidentified antioxidants. In addition it is not clear 
to what extent the lipid-soluble antioxidants in plasma, espe- 
cially ~-tocopherol and the carotenoids, are available and ac- 
cessible to participate in the reaction in methods not involving 
generation of peroxyl radicals. 
In this work a rapid, sensitive method for assessing the total 
antioxidant activity of LDL is described based on its interaction 
with the ABTS °+ [2,2'-azinobis(3-ethylbenzothiazoline-6-sul- 
phonic acid)] radical cation, an application of the previously 
established method for plasma, saliva and beverages [5,8,12]. 
The results show that the antioxidant activity of LDL correlates 
with the ~-tocopherol content, r = 0.74, the intercept presumably 
indicating the contribution from other lipophilic antioxidants. 
2. Materials and methods 
Reagents for total antioxidant activity were prepared as previously 
described [5]. Trolox (Hoffman-La Roche) (2.5 mM in buffer, pH 7.4) 
*Corresponding author. Fax: (44) (171) 955 4983. 
was used as a stock standard from which analytical standards were 
freshly prepared as required. Working solutions of hydrogen peroxide 
were freshly prepared after initial dilution to a concentration of 500 
mM. Aristar hydrogen peroxide is supplied as a 30% solution, with a 
specific gravity of 1.10: a 500 mM solution was therefore prepared by 
diluting 515 ¢tl to 10 ml and the concentration checked spectroscopi- 
cally (EmM = 39.4 at 240 rim) [13]. The assay was carried out using a 
Cobas Fara centrifugal nalyser (Roche Diagnostic Systems SA). In the 
protocol devised 250/.tl of mixed ABTS/myoglobin reagent in buffer 
was mixed with 50/11 of Trolox standard or LDL preparation (1.13- 
4.52 mg/ml LDL protein), the pipettor probe flushed with 20/tl of 
water, then 20 ¢tl of 3.125 mM hydrogen peroxide (followed by 10 ¢tl 
of water to flush the probe) added to start the reaction. The incubation 
volume was thus 350 ¢tl; reagents were prepared so that on dilution into 
this incubation volume they were at the desired final concentration 
(4.36 ¢tM metmyoglobin, 436 gM ABTS, 180 gM H202). 
Using these reagent concentrations and a temperature of 30°C the 
end of the lag phase for the highest Trolox standard (100 gM initial 
concentration, 14.30 ¢tM final concentration) was 248 s after the addi- 
tion of H202; a 248-s period between the initial and final readings was 
used as the measuring time for the assay. A dose-response curve was 
derived using a logit/log 4 plot of absorbance at734 nm against arange 
of Trolox standards (0, 2.86, 5.72, 8.58, 11.44 and 14.30 ¢tM final 
concentrations). 
The method is based on the ability of Trolox, or antioxidants within 
the LDL, to scavenge the ABTS "÷ radical cation, as detected by a 
decrease in absorbance at 734 nm. There is no interfering effect of the 
antioxidants on ABTS "÷ production, as evidenced by the fact that the 
assay can also be carried out by allowing antioxidant solutions to 
decolorise the pre-formed ABTS "÷ (unpublished ata). The use of an 
absorbance maximum in the near-IR region of the spectrum (734 nm) 
is an important feature of the assay in that sample turbidity is not a 
confounding factor at these wavelengths; LDL preparations of up to 
5 mg/ml concentration have been assayed. 
29 blood samples were obtained from patients attending a lipid clinic. 
8 samples were obtained from patients who had not taken c~-tocopherol 
supplements and 21 from patients upplemented with 300 mg dl-c~- 
tocopherol acetate daily for 9 weeks. Approval for the project was given 
by the Ethics Committee of the West Lambeth Health Authority. Blood 
was taken into acid citrate-dextrose as an anticoagulant and LDL was 
prepared from the plasma by density gradient ultracentrifugation [14]. 
The protein content of the LDL preparations was measured by the 
method of Markwell et al. [15]; values for antioxidant activity and for 
concentration of ~-tocopherol in LDL were standardised to protein 
content. LDL c~-tocopherol was measured by normal phase HPLC, 
using ~-tocopherol asan internal standard [16]. Cholesterol was meas- 
ured by the cholesterol esterase/cholesterol oxidase method (Boehringer 
Mannheim GmbH) [17]. 
The statistical significance of the degree of association between LDL 
total antioxidant activity (LDL TAA) and other measurements was 
assessed by deriving the Spearman rank-order correlation coefficient. 
3. Results 
The measured values for LDL total antioxidant activity 
(LDL TAA), c~-tocopherol, cholesterol and ~-tocopherol/ 
cholesterol ratio on 29 LDL preparations are shown in 
0014-5793/95/$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
SSDI  0014-5793(95)00448-3 
N.J. Miller et al./FEBS Letters 365 (1995) 164-166 165 
¢-  
o) 
o 50 
Q. 
E33 
E 40 
o 
E 30  ¢-- 
I1) 
t-- 20  e~ 
o 
(.3 
o 
10  
e"  
Q. 
.d  0 
121 
__1 
[ ]  [ ]  
10 20  30  40  50  
LDL TAA nMlmg protein 
Fig. 1. Plot of matched LDL TAA values (nM/mg protein) against LDL 
~-tocopherol concentrations (nmol/mg protein), n= 29, P < 0.05. 
Table 1, and separated into results from subjects not taking 
~-tocopherol supplements in Table 2 and those from subjects 
taking ~-tocopherol supplements in Table 3. All the results 
shown are expressed per mg of LDL protein to allow for vari- 
ations in the lipoprotein concentration f these preparations. 
Matched plasma ~-tocopherol, plasma cholesterol concentra- 
tions and plasma ~-tocopherol/cholesterol ratios are also 
shown. In order to investigate he association between ~-toco- 
pherol evels and measures of the total antioxidant activity of 
LDL, hyperlipidaemic patients were studied with ~-tocopherol 
levels ranging from 37.3-54.9 (unsupplemented group) and 
35.8-151.6 (supplemented) (Tables 2 and 3) giving LDL ~- 
tocopherol ranges of 11.6-19.7 (nmol/mg protein) (unsupple- 
mented) and 16.0- 47.9 (nmol/mg protein), respectively. 
No statistically significant association was observed between 
the LDL TAA and the other parameters measured in the non- 
supplemented group (using the Spearman rank-order correla- 
tion coefficient) (Table 2). However, the LDL TAA correlated 
well with both ~-tocopherol content and also ~-tocopherol/ 
cholesterol ratio in specimens from individuals who were sup- 
plementing with ~-tocopherol (Table 3). There was no negative 
(or positive) correlation between LDL TAA and LDL cholest- 
erol. There was also a good correlation between LDL total 
antioxidant activity and plasma ~-tocopherol and ~-tocophe- 
rol/cholesterol ratio; the fact that a higher degree of statistical 
significance was observed between LDL TAA and plasma cz- 
tocopherol can be interpreted as a reflection of the better pre- 
cision of the plasma measurement, involving, as it does, fewer 
analytical steps and higher ~-tocopherol values than the equiv- 
alent measurements in LDL. 
The correlation between the LDL TAA and the ~-tocopherol 
concentration in LDL of all subjects i shown in Fig. 1, r = 0.74, 
with an intercept on the TAA axis of 5.2 nanomolar of anti- 
oxidant activity/rag protein. 
4. Discuss ion 
A novel spectrophotometric method is presented for the di- 
rect measurement of the total antioxidant activity of LDL. In 
this method the ABTS radical monocation (ABTS °+) is gener- 
ated in the aqueous phase of the analytical mixture to which 
LDL is added. Nevertheless antioxidants in lipoprotein parti- 
cles were demonstrated to be capable of suppressing its forma- 
tion, although the extent o which all the minor antioxidants 
participate is unclear. The LDL TAA correlates well with the 
a-tocopherol content of the LDL in the supplemented group, 
the correlation coefficient for all samples being r -- 0.74. The 
intercept value presumably reflects the contribution from non- 
a-tocopherol antioxidants to the antioxidant s atus of the LDL 
including y-tocopherol, carotenoids, ubiquinol and possibly fla- 
vonoids [18,19]. Since ~-tocopherol and Trolox, the analytical 
standard used in the assay, have the same antioxidant activity 
in this system [5], a direct comparison of the two measurements 
is valid. Previously a method for antioxidant capacity in terms 
of the ability of LDL to inhibit peroxyl radical-dependent oxi- 
dation of luminol has been reported [20]. These authors applied 
Trolox as standard and based the calculation on the assump- 
tion that Trolox is capable of scavenging 2 peroxyl radicals per 
mole in LDL [3]. The factor of 2 difference between the gradient 
of the slope derived from their association between antioxidant 
activity and a-tocopherol content of LDL, and that described 
here is explained by the application of a 1 : 1 stoichiometry of
Trolox and the ABTS °+ radical in this system. Kagan et al. [21] 
reported mean LDL a-tocopherol concentrations of 23.0 + 2.0 
nmol/mg LDL protein, which is very close to the mean value 
of 21.6 + 1.5 nmol/mg protein detected here: whilst other 
Table 1 
LDL antioxidant activity, LDL ~-tocopherol, LDL cholesterol, LDL 
~-tocopherol/cholesterol ratio, plasma ~-tocopherol, plasma cholest- 
erol and plasma e-tocopherol/cholesterol ratio in plasma 
Mean ± S.D. Range 
LDL TAA (nM/mg protein) 
LDL ~-tocopherol (nmol/mg protein) 
LDL cholesterol (mg/mg protein) 
LDL ~-tocopherol/cholesterol ratio
Plasma ~-tocopherol (pmol/1) 
Plasma cholesterol (mmol/l) 
Plasma ~-tocopherol/cholesterol ratio
24.7 ± 3.7 17.7-31.4 
21.8 ± 8.2** 11.6-47.9 
1.40 ± 0.22 0.94-1.92 
15.5 ± 5.3** 7.7 31.3 
55.4 ± 23.0*** 35.8-151.6 
6.00 ± 0.87 4.40-7.80 
9.3 ± 3.9*** 5.7 25.4 
n = 29, mean ± S.D. shown. All LDL results are expressed as'per mg 
of LDL protein'. Correlation with LDL TAA (nM/mg protein) 
*P < 0.05, **P < 0.01, ***P < 0.005 (Spearman rank-order correlation 
coefficient). 
Table 2 
LDL antioxidant activity, LDL ~-tocopherol, LDL cholesterol, LDL 
e-tocopherol/cholesterol ratio, plasma e-tocopherol, plasma cholest- 
erol and plasma ~z-tocopherol/cholesterol rati  in plasma from subjects 
not taking ~-tocopherol supplements 
Mean ± S.D. Range 
LDL TAA (nM/mg protein) 
LDL ~-tocopherol (nmol/mg protein) 
LDL cholesterol (mg/mg protein) 
LDL ~-tocopherol/cholesterol rati  
Plasma ~-tocopherol (pmol/1) 
Plasma cholesterol (mmol/1) 
Plasma ~-tocopherol/cholesterol rati
22.6 + 2.8 17.7-26.3 
15.1 ± 2.7 11.6-19.7 
1.39 + 0.23 0.94-1.66 
11.0 ± 2.1 7.7-13.7 
45.1 _+ 6.5 37.3-54.9 
6.03 + 0.79 4.95-7.71 
7.6 + 1.7 5.9-11.1 
n = 8, mean + S.D. shown. All LDL results are expressed as'per mg 
of LDL protein'. 
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Table 3 
LDL antioxidant activity, LDL ~-tocopherol, LDL cholesterol, LDL 
~-tocopherol/cholesterol ratio, plasma 0~-tocopherol, p asma cholest- 
erol and plasma ~-tocopherol/cholesterol ratio in plasma from subjects 
supplementing with ~-tocopherol 
Mean + S.D. Range 
LDL TAA (nM/mg protein) 
LDL ~-tocopherol (nmol/mg protein) 
LDL cholesterol (mg/mg protein) 
LDL ~-tocopherol/cholesterol ratio 
Plasma ~-tocopherol Cumol/l) 
Plasma cholesterol (mmol/l) 
Plasma ~-tocopherol/cholesterol ratio 
25.5 + 3.71 19.4-31.4 
24.4 + 8.2 I'* 16.047.9 
1.43 + 0.21 1.11-1.92 
17.2 + 5.1" 10.1-31.3 
59.3 + 25.9*** 35.8-151.6 
6.00 + 0.92 4.40-7.80 
10.0 + 4.2** 5.7-25.4 
n = 21, mean + S.D. shown. All LDL results are expressed as 'per mg 
of LDL protein'. Correlation with LDL TAA (nMlmg protein) 
*P < 0.05, ** P < 0.01, ***P < 0.005 (Spearman rank-order correla- 
tion coefficient). 
t,p < 0.05 supplemented vs. non-supplemented (Table 2) (Student's 
t-test). 
authors have detected somewhat lower levels of ~-tocopherol 
in LDL of non-supplemented normal individuals (11.58 + 3.34 
nmol/mg protein [22]). The higher levels presented here reflect 
the increased lipoprotein levels of c~-tocopherol anticipated in 
plasma lipoproteins derived from hyperlipidaemic patients 
[23,241. 
The findings in this study support hose of Esterbauer et al. 
[18] who showed a correlation between ~-tocopherol content 
of LDL and its oxidation resistance (measured by lag phase to 
copper-induced oxidation) from normal, healthy individuals 
supplementing with RRR c~-tocopherol (r = 0.715), but not in 
non-supplemented volunteers, although the given effectiveness 
of c~otocopherol to increase oxidation resistance varied from 
person to person. 
The method described here will be of use in the in vitro 
investigation of factors affecting LDL oxidation, as well as in 
supplementation studies designed to assess the absorption and 
efficacy of lipophilic antioxidants. 
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